Jonathan Reuning‐Scherer

1.2k total citations
18 papers, 938 citations indexed

About

Jonathan Reuning‐Scherer is a scholar working on Radiology, Nuclear Medicine and Imaging, Radiation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jonathan Reuning‐Scherer has authored 18 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Radiation and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jonathan Reuning‐Scherer's work include Radiopharmaceutical Chemistry and Applications (6 papers), Advanced Radiotherapy Techniques (5 papers) and Urinary Tract Infections Management (3 papers). Jonathan Reuning‐Scherer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Advanced Radiotherapy Techniques (5 papers) and Urinary Tract Infections Management (3 papers). Jonathan Reuning‐Scherer collaborates with scholars based in United States, United Kingdom and Sweden. Jonathan Reuning‐Scherer's co-authors include Lisa M. Curran, David A. Talan, Gregory J. Moran, Walter E. Stamm, Thomas F. Burke, Abdollah Iravani, Thomas M. Hooton, Deborah Church, Krithi K. Karanth and Paul Cislo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Jonathan Reuning‐Scherer

17 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Reuning‐Scherer United States 10 336 192 170 163 145 18 938
James Forde Ireland 16 133 0.4× 281 1.5× 39 0.2× 29 0.2× 322 2.2× 71 958
Susan Kim Australia 22 163 0.5× 105 0.5× 39 0.2× 40 0.2× 7 0.0× 90 1.6k
John Kelly United Kingdom 17 75 0.2× 136 0.7× 362 2.1× 23 0.1× 153 1.1× 40 1.3k
M Buser Switzerland 16 116 0.3× 127 0.7× 53 0.3× 29 0.2× 52 0.4× 33 1.0k
Jeffrey Hom United States 13 179 0.5× 69 0.4× 102 0.6× 17 0.1× 12 0.1× 46 712
Yu‐Hung Lin Taiwan 16 106 0.3× 132 0.7× 164 1.0× 19 0.1× 26 0.2× 68 1.1k
Nicholas E. Bruns United States 13 125 0.4× 126 0.7× 83 0.5× 16 0.1× 7 0.0× 26 735
Thomas Steichen United States 12 56 0.2× 62 0.3× 50 0.3× 41 0.3× 11 0.1× 17 778
Peter A. Lane United States 23 53 0.2× 122 0.6× 408 2.4× 32 0.2× 5 0.0× 90 1.8k
James Henderson United States 19 125 0.4× 102 0.5× 6 0.0× 19 0.1× 16 0.1× 65 1.1k

Countries citing papers authored by Jonathan Reuning‐Scherer

Since Specialization
Citations

This map shows the geographic impact of Jonathan Reuning‐Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Reuning‐Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Reuning‐Scherer more than expected).

Fields of papers citing papers by Jonathan Reuning‐Scherer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Reuning‐Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Reuning‐Scherer. The network helps show where Jonathan Reuning‐Scherer may publish in the future.

Co-authorship network of co-authors of Jonathan Reuning‐Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Reuning‐Scherer. A scholar is included among the top collaborators of Jonathan Reuning‐Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Reuning‐Scherer. Jonathan Reuning‐Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Glick, Henry B., Peter M. Umunay, Jean‐Remy Makana, et al.. (2023). The spatial propagation and increasing dominance of Gilbertiodendron dewevrei (Fabaceae) in the eastern Congo basin. PLoS ONE. 18(2). e0275519–e0275519.
2.
Glick, Henry B., Peter M. Umunay, Jean‐Remy Makana, et al.. (2021). Developmental Dynamics of Gilbertiodendron dewevrei (Fabaceae) Drive Forest Structure and Biomass in the Eastern Congo Basin. Forests. 12(6). 738–738. 4 indexed citations
3.
Nilsson, Sten, Paul Cislo, Oliver Sartor, et al.. (2016). Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study. Annals of Oncology. 27(5). 868–874. 132 indexed citations
4.
Parker, Christopher, Lin Zhan, Paul Cislo, et al.. (2016). Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial. European Journal of Cancer. 71. 1–6. 36 indexed citations
5.
Zhan, Liying, et al.. (2015). 1230 Effect of radium-233 dichloride (Ra-223) on hospitalization and its economic implications in ALSYMPCA trial. European Journal of Cancer. 51. S183–S183. 1 indexed citations
6.
Cislo, Paul & Jonathan Reuning‐Scherer. (2015). Effect of radium-223 dichloride (Ra-223) on risk for and duration of hospitalization in ALSYMPCA by docetaxel (D) subgroup.. Journal of Clinical Oncology. 33(7_suppl). 254–254. 1 indexed citations
7.
Chao, Ariana M., Margaret Grey, Robin Whittemore, et al.. (2015). Examining the mediating roles of binge eating and emotional eating in the relationships between stress and metabolic abnormalities. Journal of Behavioral Medicine. 39(2). 320–332. 23 indexed citations
8.
Cislo, Paul, Oliver Sartor, Jonathan Reuning‐Scherer, et al.. (2015). 673 Effects of radium-223 dichloride (Ra-223) on health-related quality of life (HRQoL) assessed by the EQ-5D utility scores in ALSYMPCA. European Urology Supplements. 14(2). e673–e673a. 8 indexed citations
9.
Nilsson, Sten, Michael Tomblyn, Paul Cislo, Jonathan Reuning‐Scherer, & Chris Parker. (2014). Patient-reported quality of life (QOL) analysis of radium-223 dichloride (Ra-223) evaluating pain relief from the phase 3 ALSYMPCA study.. Journal of Clinical Oncology. 32(15_suppl). 5069–5069. 8 indexed citations
10.
Cislo, Paul & Jonathan Reuning‐Scherer. (2014). Effects of radium-223 dichloride (Ra-223) on risk for hospitalization and health care resource use in the phase 3 ALSYMPCA trial.. Journal of Clinical Oncology. 32(30_suppl). 21–21. 4 indexed citations
11.
Parker, Chris, Daniel Heinrich, David Bottomley, et al.. (2013). Effects of radium-223 dichloride (Ra-223) on health-related quality of life (QOL) outcomes in the phase 3 ALSYMPCA study in patients with castration-resistant prostate cancer (CRPC) and bone metastases. European Journal of Cancer. 49. 2 indexed citations
12.
Balch, Jennifer K., Daniel C. Nepstad, Lisa M. Curran, et al.. (2010). Size, species, and fire behavior predict tree and liana mortality from experimental burns in the Brazilian Amazon. Forest Ecology and Management. 261(1). 68–77. 98 indexed citations
13.
Karanth, Krithi K., Lisa M. Curran, & Jonathan Reuning‐Scherer. (2005). Village size and forest disturbance in Bhadra Wildlife Sanctuary, Western Ghats, India. Biological Conservation. 128(2). 147–157. 95 indexed citations
14.
Gomolin, Irving H., et al.. (2001). Efficacy and Safety of Ciprofloxacin Oral Suspension Versus Trimethoprim‐Sulfamethoxazole Oral Suspension for Treatment of Older Women with Acute Urinary Tract Infection. Journal of the American Geriatrics Society. 49(12). 1606–1613. 21 indexed citations
15.
Gomolin, Irving H., et al.. (2001). Efficacy and Safety of Ciprofloxacin Oral Suspension Versus Trimethoprim-Sulfamethoxazole Oral Suspension for Treatment of Older Women with Acute Urinary Tract Infection. Journal of the American Geriatrics Society. 49(12). 1606–1613. 26 indexed citations
16.
Talan, David A., Walter E. Stamm, Thomas M. Hooton, et al.. (2000). Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.. PubMed. 283(12). 1583–90. 343 indexed citations
17.
Doraiswamy, P. Murali, Florian Bieber, Lee Kaiser, et al.. (1997). The Alzheimer's disease assessment scale. Neurology. 48(6). 1511–1517. 122 indexed citations
18.
Doraiswamy, P. Murali, Florian Bieber, Lee Kaiser, et al.. (1997). Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations.. PubMed. 33(1). 123–8. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026